| Betterchem |
|
|
| FDA approval activities
for this prescription drug:
Bumex (bumetanide) Tablets & Bumex (bumetanide) Injection, 0.25, 1 and 2 mg & 0.25 mg/mL, respectively, Hoffmann-La Roche NDA 18-225/S-018 & 019 & 18-226/S-024 & 025 10/29/02 11/19/02 3/7/03 Bumex (bumetanide) Tablets, 0.25, 1 and 2 mg, Hoffmann-La Roche NDA 18-225/S22 BUMETANIDE Injection 0.25MG/ML BUMETANIDE ABBOTT 074332 BUMETANIDE Injection 0.25MG/ML BUMETANIDE ABBOTT 074441 BUMETANIDE Injection 0.25MG/ML BUMETANIDE BEDFORD 074613 BUMETANIDE Injection 0.25MG/ML BUMETANIDE GENSIA SICOR 018226 BUMETANIDE Injection 0.25MG/ML BUMEX ROCHE 074700 BUMETANIDE Tablet; 0.5MG BUMETANIDE EON 074700 BUMETANIDE Tablet; 1MG BUMETANIDE EON 074700 BUMETANIDE Tablet; 2MG BUMETANIDE EON 074225 BUMETANIDE Tablet; 0.5MG BUMETANIDE IVAX 074225 BUMETANIDE Tablet; 1MG BUMETANIDE IVAX 074225 BUMETANIDE Tablet; 2MG BUMETANIDE IVAX 018225 BUMETANIDE Tablet; 0.5MG BUMEX ROCHE 018225 BUMETANIDE Tablet; 1MG BUMEX ROCHE 018225 BUMETANIDE Tablet; 2MG BUMEX ROCHE |
© 2007 Betterchem Corp.
|